Parkinson’s Disease

1. Butler, N. (2010), ‘Parkinson’s Disease Guidelines’, SA Pharmaceutical Journal 2. Kies, C.B. and Fine, J. (2009), ‘Guideline for the Treatment of Parkinson’s Disease’, SAMJ, vol.99, no. 10. 3. De Maagd, G. and Philip, A. (2015), ‘Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation and Diagnosis’, Parkinson’s Disease and its Management, 40(8), pp. 504-510, 532. 4. Davie, C. A. (2008), ‘A Review of Parkinson’s Disease’, British Medical Bulletin, vol. 86, no.1, pp. 109-127. 5. Jankovic, J. (2008), ‘Parkinson’s Disease: Clinical Features and Diagnosis’, Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 4. 6. Savitt, J.M., Dawson, V.L. and Dawson, T.M. (2006), ‘Diagnosis and Treatment of Parkinson Disease: Molecules to Medicine’, The Journal of Clinical Investigation. Ayano, G. (2016), ‘Parkinson’s Disease; A Concise Overview of Etiology, Epidemiology, Diagnosis, Comorbidity and Management’, Journal of Neurological Disorders. Brought to you by cipla Related Information POST-TRAUMATIC STRESS DISORDER (PTSD) PTSD is a serious and often debilitating medical condition that can occur in anyone who has experienced a traumatic event DEPRESSION MEDICATION SUPPLEMENT Depression is a common medical condition that has a big impact on a large number of areas in peoples’ lives DEMENTIA Dementia is the umbrella term for a range of progressive neurological disorders affecting brain functioning, including Alzheimer’s disease ANXIETY DISORDER There are five major anxiety disorders, and one of the most common is generalised anxiety disorder or GAD.